18 June 2013
Keywords: zyban, outperforms, nicotine, patches, glaxo, wellcome, nicotine-free
Article | 05 March 1999
Glaxo Wellcome's nicotine-free product for smoking cessation, Zyban(bupropion HCl), has been shown to be nearly twice as effective in
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 March 1999
4 March 1999
17 June 2013
© 2013 thepharmaletter.com